These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
655 related items for PubMed ID: 26164356
1. Serum albumin-adjusted glycated albumin reflects glycemic excursion in diabetic patients with severe chronic kidney disease not treated with dialysis. Fukami K, Shibata R, Nakayama H, Yamada K, Okuda S, Koga M. J Diabetes Complications; 2015; 29(7):913-7. PubMed ID: 26164356 [Abstract] [Full Text] [Related]
2. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Fukami K, Shibata R, Nakayama H, Yamada K, Okuda S, Koga M. Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140 [Abstract] [Full Text] [Related]
3. The clinical usefulness of glycated albumin in patients with diabetes and chronic kidney disease: Progress and challenges. Gan T, Liao B, Xu G. J Diabetes Complications; 2018 Sep; 32(9):876-884. PubMed ID: 30049445 [Abstract] [Full Text] [Related]
6. Glycated albumin in diabetic patients with chronic kidney disease. Zheng CM, Ma WY, Wu CC, Lu KC. Clin Chim Acta; 2012 Oct 09; 413(19-20):1555-61. PubMed ID: 22579765 [Abstract] [Full Text] [Related]
9. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection. Inaba M, Okuno S, Kumeda Y, Yamada S, Imanishi Y, Tabata T, Okamura M, Okada S, Yamakawa T, Ishimura E, Nishizawa Y, Osaka CKD Expert Research Group. J Am Soc Nephrol; 2007 Mar 09; 18(3):896-903. PubMed ID: 17267743 [Abstract] [Full Text] [Related]
10. Serum albumin-adjusted glycated albumin is a better predictor of mortality in diabetic patients with end-stage renal disease on hemodialysis. Yajima T, Yajima K, Hayashi M, Yasuda K, Takahashi H, Yamakita N. J Diabetes Complications; 2016 Jul 09; 30(5):786-9. PubMed ID: 27009773 [Abstract] [Full Text] [Related]
13. Glycated albumin and the risk of chronic kidney disease in subjects with Type 2 Diabetes: A study in North Indian Population. Raghav A, Ahmad J, Noor S, Alam K, Mishra BK. Diabetes Metab Syndr; 2018 May 09; 12(3):381-385. PubMed ID: 29396252 [Abstract] [Full Text] [Related]
14. Determination of serum glycated albumin and high sensitivity C - reactive protein in the insight of cardiovascular complications in diabetic chronic kidney disease patients. Vijayaraghavan B, Padmanabhan G, Ramanathan K. Afr Health Sci; 2020 Mar 09; 20(1):308-313. PubMed ID: 33402919 [Abstract] [Full Text] [Related]
18. Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T. Intern Med; 2011 Mar 09; 50(1):23-9. PubMed ID: 21212569 [Abstract] [Full Text] [Related]
19. Distinct biomarker roles for HbA1c and glycated albumin in patients with type 2 diabetes on hemodialysis. Hayashi A, Takano K, Masaki T, Yoshino S, Ogawa A, Shichiri M. J Diabetes Complications; 2016 Mar 09; 30(8):1494-1499. PubMed ID: 27614726 [Abstract] [Full Text] [Related]